BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38037829)

  • 21. Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients.
    Thokala P; Arrowsmith M; Poku E; Martyn-St James M; Anderson J; Foster S; Elliott T; Whitehouse T
    J Infect Prev; 2016 Sep; 17(5):216-223. PubMed ID: 27582899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
    Schwebel C; Lucet JC; Vesin A; Arrault X; Calvino-Gunther S; Bouadma L; Timsit JF
    Crit Care Med; 2012 Jan; 40(1):11-7. PubMed ID: 21926570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing bloodstream infection with a chlorhexidine gel IV dressing.
    Jeanes A; Bitmead J
    Br J Nurs; 2015 Oct 22-Nov 11; 24(19):S14-9. PubMed ID: 26496869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily skin cleansing with chlorhexidine did not reduce the rate of central-line associated bloodstream infection in a surgical intensive care unit.
    Popovich KJ; Hota B; Hayes R; Weinstein RA; Hayden MK
    Intensive Care Med; 2010 May; 36(5):854-8. PubMed ID: 20213074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of the CHlorhexidine Gluconate Bathing implementation intervention to improve evidence-based nursing practices for prevention of central line associated bloodstream infections Study (CHanGing BathS): a stepped wedge cluster randomized trial.
    Reynolds SS; Woltz P; Keating E; Neff J; Elliott J; Hatch D; Yang Q; Granger BB
    Implement Sci; 2021 Apr; 16(1):45. PubMed ID: 33902653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.
    Crawford AG; Fuhr JP; Rao B
    Infect Control Hosp Epidemiol; 2004 Aug; 25(8):668-74. PubMed ID: 15357159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorhexidine gluconate–impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases.
    Weitz NA; Lauren CT; Weiser JA; LeBoeuf NR; Grossman ME; Biagas K; Garzon MC; Morel KD
    JAMA Dermatol; 2013 Feb; 149(2):195-9. PubMed ID: 23560299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
    Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
    Maunoury F; Motrunich A; Palka-Santini M; Bernatchez SF; Ruckly S; Timsit JF
    PLoS One; 2015; 10(6):e0130439. PubMed ID: 26086783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis patients.
    Marty Cooney R; Manickam N; Becherer P; Harmon LS; Gregg L; Farkas Z; Shea LM; Parekh P; Murphy J; Shade W
    Br J Nurs; 2020 Jan; 29(2):S24-S26. PubMed ID: 31972108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial Activity of a Novel Vascular Access Film Dressing Containing Chlorhexidine Gluconate.
    Wibaux A; Thota P; Mastej J; Prince DL; Carty N; Johnson P
    PLoS One; 2015; 10(11):e0143035. PubMed ID: 26599087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorhexidine-based versus non-chlorhexidine dressings to prevent catheter-related bloodstream infections: An evidence-based review.
    Azzopardi A; Trapani J
    Nurs Crit Care; 2024 Jan; 29(1):191-195. PubMed ID: 36579384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a chlorhexidine-impregnated dressing reduced catheter-related bloodstream infections caused by Gram-positive microorganisms.
    Ergul AB; Gokcek I; Ozcan A; Cetin S; Gultekin N; Torun YA
    Pak J Med Sci; 2018; 34(2):347-351. PubMed ID: 29805406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Multicenter Pragmatic Interrupted Time Series Analysis of Chlorhexidine Gluconate Bathing in Community Hospital Intensive Care Units.
    Dicks KV; Lofgren E; Lewis SS; Moehring RW; Sexton DJ; Anderson DJ
    Infect Control Hosp Epidemiol; 2016 Jul; 37(7):791-7. PubMed ID: 26861417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biofilm Formation on Central Venous Catheters: A Pilot Study.
    Niemann B; Dudas L; Gray D; Pettit A; Wilson A; Bardes JM
    J Surg Res; 2022 Dec; 280():123-128. PubMed ID: 35964484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
    Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
    Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlorhexidine gluconate transparent dressing does not decrease central line-associated bloodstream infection in critically ill patients: A randomized controlled trial.
    Yu K; Lu M; Meng Y; Zhao Y; Li Z
    Int J Nurs Pract; 2019 Dec; 25(6):e12776. PubMed ID: 31631496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlorhexidine-containing dressings in the prevention of central venous catheter-related bloodstream infections: A cost and resource utilization analysis.
    Heimann SM; Biehl LM; Vehreschild JJ; Franke B; Cornely OA; Vehreschild MJGT
    Am J Infect Control; 2018 Sep; 46(9):992-997. PubMed ID: 29661631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiseptic solutions for skin preparation during central catheter insertion in neonates.
    Muhd Helmi MA; Lai NM; Van Rostenberghe H; Ayub I; Mading E
    Cochrane Database Syst Rev; 2023 May; 5(5):CD013841. PubMed ID: 37142550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.